In our study, the serum levels of adipocytokines IL-6, IL-1β, TNF-α, and MCP-1 in the CH treatment group were all significantly lower when compared to those in the HFD group (p < 0.05, Figure 5A–D). The gene discussed is CCL2; the disease is cyclic hematopoiesis.